Cargando…

Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis

Rice bran arabinoxylan compound (RBAC) is a polysaccharide modified by Lentinus edodes mycelial enzyme widely used as a nutraceutical. To explore translational research on RBAC, a scoping review was conducted to synthesise research evidence from English (MEDLINE, ProQuest, CENTRAL, Emcare, CINAHL+,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooi, Soo Liang, Micalos, Peter S., Pak, Sok Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470915/
https://www.ncbi.nlm.nih.gov/pubmed/37651416
http://dx.doi.org/10.1371/journal.pone.0290314
_version_ 1785099788723683328
author Ooi, Soo Liang
Micalos, Peter S.
Pak, Sok Cheon
author_facet Ooi, Soo Liang
Micalos, Peter S.
Pak, Sok Cheon
author_sort Ooi, Soo Liang
collection PubMed
description Rice bran arabinoxylan compound (RBAC) is a polysaccharide modified by Lentinus edodes mycelial enzyme widely used as a nutraceutical. To explore translational research on RBAC, a scoping review was conducted to synthesise research evidence from English (MEDLINE, ProQuest, CENTRAL, Emcare, CINAHL+, Web of Science), Japanese (CiNii, J-Stage), Korean (KCI, RISS, ScienceON), and Chinese (CNKI, Wanfang) sources while combining bibliometrics and network analyses for data visualisation. Searches were conducted between September and October 2022. Ninety-eight articles on RBAC and the biological activities related to human health or disease were included. Research progressed with linear growth (median = 3/year) from 1998 to 2022, predominantly on Biobran MGN-3 (86.73%) and contributed by 289 authors from 100 institutions across 18 countries. Clinical studies constitute 61.1% of recent articles (2018 to 2022). Over 50% of the research was from the USA (29/98, 29.59%) and Japan (22/98, 22.45%). A shifting focus from immuno-cellular activities to human translations over the years was shown via keyword visualisation. Beneficial effects of RBAC include immunomodulation, synergistic anticancer properties, hepatoprotection, antiinflammation, and antioxidation. As an oral supplement taken as an adjuvant during chemoradiotherapy, cancer patients reported reduced side effects and improved quality of life in human studies, indicating RBAC’s impact on the psycho-neuro-immune axis. RBAC has been studied in 17 conditions, including cancer, liver diseases, HIV, allergy, chronic fatigue, gastroenteritis, cold/flu, diabetes, and in healthy participants. Further translational research on the impact on patient and community health is required for the evidence-informed use of RBAC in health and disease.
format Online
Article
Text
id pubmed-10470915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104709152023-09-01 Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis Ooi, Soo Liang Micalos, Peter S. Pak, Sok Cheon PLoS One Research Article Rice bran arabinoxylan compound (RBAC) is a polysaccharide modified by Lentinus edodes mycelial enzyme widely used as a nutraceutical. To explore translational research on RBAC, a scoping review was conducted to synthesise research evidence from English (MEDLINE, ProQuest, CENTRAL, Emcare, CINAHL+, Web of Science), Japanese (CiNii, J-Stage), Korean (KCI, RISS, ScienceON), and Chinese (CNKI, Wanfang) sources while combining bibliometrics and network analyses for data visualisation. Searches were conducted between September and October 2022. Ninety-eight articles on RBAC and the biological activities related to human health or disease were included. Research progressed with linear growth (median = 3/year) from 1998 to 2022, predominantly on Biobran MGN-3 (86.73%) and contributed by 289 authors from 100 institutions across 18 countries. Clinical studies constitute 61.1% of recent articles (2018 to 2022). Over 50% of the research was from the USA (29/98, 29.59%) and Japan (22/98, 22.45%). A shifting focus from immuno-cellular activities to human translations over the years was shown via keyword visualisation. Beneficial effects of RBAC include immunomodulation, synergistic anticancer properties, hepatoprotection, antiinflammation, and antioxidation. As an oral supplement taken as an adjuvant during chemoradiotherapy, cancer patients reported reduced side effects and improved quality of life in human studies, indicating RBAC’s impact on the psycho-neuro-immune axis. RBAC has been studied in 17 conditions, including cancer, liver diseases, HIV, allergy, chronic fatigue, gastroenteritis, cold/flu, diabetes, and in healthy participants. Further translational research on the impact on patient and community health is required for the evidence-informed use of RBAC in health and disease. Public Library of Science 2023-08-31 /pmc/articles/PMC10470915/ /pubmed/37651416 http://dx.doi.org/10.1371/journal.pone.0290314 Text en © 2023 Ooi et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ooi, Soo Liang
Micalos, Peter S.
Pak, Sok Cheon
Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title_full Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title_fullStr Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title_full_unstemmed Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title_short Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
title_sort modified rice bran arabinoxylan as a nutraceutical in health and disease—a scoping review with bibliometric analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470915/
https://www.ncbi.nlm.nih.gov/pubmed/37651416
http://dx.doi.org/10.1371/journal.pone.0290314
work_keys_str_mv AT ooisooliang modifiedricebranarabinoxylanasanutraceuticalinhealthanddiseaseascopingreviewwithbibliometricanalysis
AT micalospeters modifiedricebranarabinoxylanasanutraceuticalinhealthanddiseaseascopingreviewwithbibliometricanalysis
AT paksokcheon modifiedricebranarabinoxylanasanutraceuticalinhealthanddiseaseascopingreviewwithbibliometricanalysis